Simulation of patient organ doses and effective doses originating from secondary neutrons in proton beam treatment
Jiang H., Wang B., Xu X.G., Suit H.D., and Paganetti H. Simulation of patient organ doses and effective doses originating from secondary neutrons in proton beam treatment. Phys Med Biol 50 (2005) 4337-4354
Neutron scattered dose equivalent to a fetus from proton radiotherapy of the mother
Mesoloras G., Sandison G.A., Stewart R.D., Farr J.B., and Hsi W.C. Neutron scattered dose equivalent to a fetus from proton radiotherapy of the mother. Med Phys 33 (2006) 2479-2490
Secondary neutron dose during proton therapy using spot scanning
Schneider U., Agosteo S., Pedroni E., and Besserer J. Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys 53 (2002) 244-251
Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery
Brenner D.J., Curtis R.E., Hall E.J., and Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 88 (2000) 398-405
Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors
Miralbell R., Lomax A., Cella L., and Schneider U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 54 (2001) 824-829
Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin's disease with photon and proton radiation
Schneider U., Lomax A., and Lombriser N. Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin's disease with photon and proton radiation. Radiat Res 154 (2000) 382-388
